These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

376 related items for PubMed ID: 18457672

  • 1. Levels of asymmetric dimethylarginine, nitric oxide and lipid peroxidation markers in patients with end-stage renal disease having peritoneal dialysis treatment.
    Göçmen AY, Sahin E, Koçak H, Tuncer M, Gümüşlü S.
    Clin Biochem; 2008 Jul; 41(10-11):836-40. PubMed ID: 18457672
    [Abstract] [Full Text] [Related]

  • 2. Increased (E)-4-hydroxy-2-nonenal and asymmetric dimethylarginine concentrations and decreased nitric oxide concentrations in the plasma of patients with major depression.
    Selley ML.
    J Affect Disord; 2004 Jun; 80(2-3):249-56. PubMed ID: 15207938
    [Abstract] [Full Text] [Related]

  • 3. Serum oxidized low density lipoprotein, paraoxonase 1 and lipid peroxidation levels during oral glucose tolerance test.
    Serin O, Konukoglu D, Firtina S, Mavis O.
    Horm Metab Res; 2007 Mar; 39(3):207-11. PubMed ID: 17373636
    [Abstract] [Full Text] [Related]

  • 4. Serum leptin, resistin, and lipid levels in patients with end stage renal failure with regard to dialysis modality.
    Taskapan MC, Taskapan H, Sahin I, Keskin L, Atmaca H, Ozyalin F.
    Ren Fail; 2007 Mar; 29(2):147-54. PubMed ID: 17365928
    [Abstract] [Full Text] [Related]

  • 5. Oxidized low-density lipoprotein biomarkers in patients with end-stage renal failure: acute effects of hemodialysis.
    Bossola M, Tazza L, Merki E, Giungi S, Luciani G, Miller ER, Lin EB, Tortorelli A, Tsimikas S.
    Blood Purif; 2007 Mar; 25(5-6):457-65. PubMed ID: 18075247
    [Abstract] [Full Text] [Related]

  • 6. Effect of oxidative stress on antioxidant enzyme activities, homocysteine and lipoproteins in chronic kidney disease.
    Atamer A, Kocyigit Y, Ecder SA, Selek S, Ilhan N, Ecder T, Atamer Y.
    J Nephrol; 2008 Mar; 21(6):924-30. PubMed ID: 19034878
    [Abstract] [Full Text] [Related]

  • 7. Electronegative LDL and lipid abnormalities in patients undergoing hemodialysis and peritoneal dialysis.
    Lobo J, Santos F, Grosso D, Lima R, Barreira AL, Leite M, Mafra D, Abdalla DS.
    Nephron Clin Pract; 2008 Mar; 108(4):c298-304. PubMed ID: 18434752
    [Abstract] [Full Text] [Related]

  • 8. Lipid peroxidation and parathyroid hormone influence the cytosolic calcium levels of erythrocytes in peritoneal dialysis patients.
    Sahin E, Goçmen AY, Gümüşlü S, Sahin M, Koçak H, Tuncer M.
    Clin Lab; 2011 Mar; 57(7-8):551-7. PubMed ID: 21888020
    [Abstract] [Full Text] [Related]

  • 9. Association of serum paraoxonase activity with insulin sensitivity and oxidative stress in hyperthyroid and TSH-suppressed nodular goitre patients.
    Yavuz DG, Yüksel M, Deyneli O, Ozen Y, Aydin H, Akalin S.
    Clin Endocrinol (Oxf); 2004 Oct; 61(4):515-21. PubMed ID: 15473886
    [Abstract] [Full Text] [Related]

  • 10. Lipoperoxidation and hemodialysis.
    Ramos R, Martínez-Castelao A.
    Metabolism; 2008 Oct; 57(10):1369-74. PubMed ID: 18803940
    [Abstract] [Full Text] [Related]

  • 11. Asymmetrical (ADMA) and symmetrical dimethylarginine (SDMA) as potential risk factors for cardiovascular and renal outcome in chronic kidney disease - possible candidates for paradoxical epidemiology?
    Busch M, Fleck C, Wolf G, Stein G.
    Amino Acids; 2006 May; 30(3):225-32. PubMed ID: 16680555
    [Abstract] [Full Text] [Related]

  • 12. Effect of dialysis type on serum lipids, apolipoproteins, and lipoproteins.
    Kanbay M, Delibasi T, Kaya A, Aydogan T, Koca C, Akcay A, Duranay M, Yigitoglu R.
    Ren Fail; 2006 May; 28(7):567-71. PubMed ID: 17050239
    [Abstract] [Full Text] [Related]

  • 13. [Assessment of malonyldialdehyde concentration as a product of lipid peroxidation and lipid metabolism in patients on chronic dialysis].
    Miler M, Zamojska S, Fijałkowski P, Lobos M, Paradowski MT.
    Pol Merkur Lekarski; 2006 Jun; 20(120):664-7. PubMed ID: 17007263
    [Abstract] [Full Text] [Related]

  • 14. Administration of exogenous erythropoietin beta affects lipid peroxidation and serum paraoxonase-1 activity and concentration in predialysis patients with chronic renal disease and anaemia.
    Marsillach J, Martínez-Vea A, Marcas L, Mackness B, Mackness M, Ferré N, Joven J, Camps J.
    Clin Exp Pharmacol Physiol; 2007 Apr; 34(4):347-9. PubMed ID: 17324148
    [Abstract] [Full Text] [Related]

  • 15. The determination of insulin sensitivity in hemodialysis and continuous ambulatory peritoneal dialysis in nondiabetic patients with end-stage renal disease.
    Tuzcu A, Bahceci M, Yilmaz ME, Turgut C, Kara IH.
    Saudi Med J; 2005 May; 26(5):786-91. PubMed ID: 15951871
    [Abstract] [Full Text] [Related]

  • 16. Oxidative stress and high-density lipoprotein function in Type I diabetes and end-stage renal disease.
    Kalogerakis G, Baker AM, Christov S, Rowley KG, Dwyer K, Winterbourn C, Best JD, Jenkins AJ.
    Clin Sci (Lond); 2005 Jun; 108(6):497-506. PubMed ID: 15634192
    [Abstract] [Full Text] [Related]

  • 17. [Lipoprotein (a) in children with end stage renal failure on maintenance hemodialysis and continuous ambulatory peritoneal dialysis].
    Zwolińska D, Szprynger K.
    Przegl Lek; 1997 Jun; 54(5):320-3. PubMed ID: 9380806
    [Abstract] [Full Text] [Related]

  • 18. Cu/Zn superoxide dismutase plasma levels as a new useful clinical biomarker of oxidative stress in patients with end-stage renal disease.
    Pawlak K, Pawlak D, Mysliwiec M.
    Clin Biochem; 2005 Aug; 38(8):700-5. PubMed ID: 15963971
    [Abstract] [Full Text] [Related]

  • 19. Plasma concentrations of non-esterified fatty acids in chronic renal failure in the United Arab Emirates.
    Gillett MP, Obineche EN, Khan ST, Abdulle AM.
    Saudi Med J; 2004 Nov; 25(11):1611-6. PubMed ID: 15573187
    [Abstract] [Full Text] [Related]

  • 20. Serum paraoxonase activity in uremic predialysis and hemodialysis patients.
    Dirican M, Akca R, Sarandol E, Dilek K.
    J Nephrol; 2004 Nov; 17(6):813-8. PubMed ID: 15593056
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.